跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,588 条关于
“Shanghai Take Biotechnology Co.”
全部
20,588
临床试验
4,918
药物
2,097
机构
1,779
资讯
11,794
3个月前
Dual-Target CD19/BCMA CAR T-Cell Therapy Demonstrates Profound Remission in Refractory Systemic Sclerosis
去年
Cyrus Biotechnology Advances AI-Optimized IdeS for Autoimmune Diseases Following Nobel Prize for Co-founder
上个月
Shanghai Industry Association Issues First-Ever Technical Standard for Plant-Derived Exosome-Like Nanovesicles
去年
FDA Approves Shanghai Henlius Biotech's Novel ALS Drug HLX99
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
KEYNOTE-057 Trial Explores Vibostolimab and Favezelimab Combinations with Pembrolizumab in BCG-Unresponsive NMIBC
去年
BioDuro-Sundia Expands Shanghai Operations with New Kilogram Laboratory and Compound Management Center
去年
Fosun Pharma's Innovative Drug Receives Registration Acceptance in China
去年
WORK Medical and Shanghai Chartwell Form Strategic Alliance to Advance High-End Medical Technologies
去年
Henlius Receives Approval for HLX10 in China, Expanding Oncology Portfolio
第 1 页,共 1180 页
上一页
下一页